Allan Catherine K, Thiagarajan Ravi R, Armsby Laurie R, del Nido Pedro J, Laussen Peter C
Department of Cardiology, Children's Hospital, Boston and Harvard Medical School, Boston, MA.
Pediatr Crit Care Med. 2006 May;7(3):212-9. doi: 10.1097/01.PCC.0000200964.88206.B0.
The goal of this study was to evaluate the utility of extracorporeal membrane oxygenation (ECMO) to resuscitate patients following critical cardiac events in the catheterization laboratory.
Retrospective review of medical records.
Cardiac intensive care unit and cardiac catheterization laboratory at a tertiary care children's hospital.
Pediatric patients cannulated emergently for ECMO in the cardiac catheterization laboratory (n = 22).
ECMO was initiated emergently in the cardiac catheterization laboratory for progressive hemodynamic deterioration due to low cardiac output syndrome or catheter-induced complications.
Twenty-two patients were cannulated for ECMO in the catheterization laboratory between 1996 and 2004. Median age was 33 months (range 0-192), median weight 14.8 kg (2.4-75), and median duration of ECMO 84 hrs (2-343). Indications included catheter-induced complication (n = 14), severe low cardiac output syndrome (n = 7), and hypoxemia (n = 1). Three patients (14%) were cannulated in the catheterization laboratory before catheterization for low cardiac output or hypoxemia. During cannulation, 19 patients (86%) were receiving chest compressions; median duration of cardiopulmonary resuscitation was 29 mins (20-57). Eighteen patients (82%) survived to discharge (five of whom underwent cardiac transplantation) and four (18%) died. Of 19 patients who received cardiopulmonary resuscitation during cannulation, 15 (79%) survived to discharge and nine (47%) sustained neurologic injury. There was no significant difference between survivors and nonsurvivors in age, weight, duration of cardiopulmonary resuscitation or ECMO support, pH, or lactate levels.
ECMO is a technically feasible and highly successful tool in the resuscitation of pediatric patients following critical events in the cardiac catheterization laboratory.
本研究的目的是评估体外膜肺氧合(ECMO)在导管实验室对心脏危急事件后患者进行复苏的效用。
对病历进行回顾性研究。
一家三级儿童医院的心脏重症监护病房和心脏导管实验室。
在心脏导管实验室紧急进行ECMO插管的儿科患者(n = 22)。
因低心排血量综合征或导管相关并发症导致血流动力学进行性恶化时,在心脏导管实验室紧急启动ECMO。
1996年至2004年间,22例患者在导管实验室接受了ECMO插管。中位年龄为33个月(范围0 - 192个月),中位体重14.8 kg(2.4 - 75 kg),ECMO中位持续时间84小时(2 - 343小时)。适应证包括导管相关并发症(n = 14)、严重低心排血量综合征(n = 7)和低氧血症(n = 1)。3例患者(14%)在导管插入术前因低心排血量或低氧血症在导管实验室进行了插管。插管期间,19例患者(86%)正在接受胸外按压;心肺复苏的中位持续时间为29分钟(20 - 57分钟)。18例患者(82%)存活至出院(其中5例接受了心脏移植),4例(18%)死亡。在插管期间接受心肺复苏的19例患者中,15例(79%)存活至出院,9例(47%)发生神经损伤。存活者与非存活者在年龄、体重、心肺复苏或ECMO支持持续时间、pH值或乳酸水平方面无显著差异。
ECMO是在心脏导管实验室对儿科患者进行危急事件复苏的一项技术上可行且非常成功的工具。